5 Key Takeaways

• 1

  Wearable and implantable devices enhance continuous intraocular pressure (IOP) monitoring, addressing limitations of traditional tonometry.

• 2

  Continuous monitoring technologies can detect diurnal and nocturnal IOP fluctuations, improving risk stratification in glaucoma management.

• 3

  The Sensimed Triggerfish is a widely studied contact lens-based sensor that captures IOP changes during daily activities, correlating well with standard tonometry.

• 4

  Implantable bioMEMS sensors, such as the Eyemate-IO, enable long-term IOP monitoring but require surgical implantation and have associated risks.

• 5

  Both CLBS and bioMEMS devices show promise for individualized treatment strategies, though challenges like measurement drift and calibration persist.